beta-rubromycin

structure given in first source

Also Known As:

Spiro(benzo(1,2-b:5,4-c')dipyran-2(3H),2'(3'H)-naphtho(1,2-b)furan)-7-carboxylic acid, 4,4',5',9-tetrahydro-6',10-dihydroxy-7',9'-dimethoxy-4',5',9-trioxo-, methyl ester

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Quinones: 434
  - beta-rubromycin: 1

Experts

1.	Goto, Y: 1 article (05/2000)
2.	Hayashi, H: 1 article (05/2000)
3.	Mizunuma, M: 1 article (05/2000)
4.	Mizushina, Y: 1 article (05/2000)
5.	Oda, M: 1 article (05/2000)
6.	Sakaguchi, K: 1 article (05/2000)
7.	Takahashi, H: 1 article (05/2000)
8.	Ueno, T: 1 article (05/2000)
9.	Yokoyama, A: 1 article (05/2000)

Related Diseases

1.	Neoplasms (Cancer) 05/23/2000 - "Although beta-rubromycin showed nonspecific cytotoxicities, reducing proliferation of cancer cells (IC(50) approximately 20 microM), we conclude that beta-rubromycin appears to be a lead structure for the development of more potent and selective inhibitors of human telomerase."

Related Drugs and Biologics

1.	Telomerase (Telomerase Reverse Transcriptase)